Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study to Investigate The Mass Balance and Biotransformation of WPV01 in Healthy Adult Chinese Male Participants

NCT07080658 is registered in ClinicalTrials.gov with Westlake Pharmaceuticals (Hangzhou) Co., Ltd. as lead sponsor.

NCT NCT07080658
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07080658 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study to Investigate The Mass Balance and Biotransformation of WPV01 in Healthy Adult Chinese Male Participants
Lead sponsor
Westlake Pharmaceuticals (Hangzhou) Co., Ltd.
Phase
Phase 1
Overall status
Completed
Start date
July 23, 2023
Completion date
August 6, 2023
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19